GLP-1 Injection Sites: Where to Inject Ozempic, Wegovy, and Zepbound

Quick Answer

All GLP-1 medications — Ozempic, Wegovy, Mounjaro, and Zepbound — are injected subcutaneously (into the fat under the skin) at one of three sites: abdomen, outer thigh, or upper arm. The abdomen is preferred for most patients. Rotating injection sites weekly prevents scar tissue and maintains consistent drug absorption.

Approved Injection Sites for GLP-1 Medications

All four major GLP-1 medications share the same approved injection sites — this is consistent across semaglutide and tirzepatide products:

Abdomen

Inject into the soft tissue of the belly, at least 2 inches (5 cm) away from the navel
Use the area between the bottom of the ribcage and the top of the hip bones
Avoid the navel, any scars, stretch marks, bruising, or irritated skin
Most commonly used site — largest subcutaneous fat area, most accessible for self-injection

Outer Thigh

Use the middle third of the outer thigh (not the inner thigh)
The outer thigh is easy to visualize when self-injecting
Absorption is equivalent to the abdomen for most patients
Avoid the front or inner thigh (more muscle, more nerves)

Upper Arm

Use the back of the upper arm — the fatty area behind the tricep
This site is difficult to reach for self-injection and typically requires assistance
Preferred by some patients who want to avoid the abdomen and thighs
Absorption is generally equivalent

Which Site Is Best?

For most patients, the abdomen is the recommended primary site. The reasons:

Largest subcutaneous fat area → most consistent absorption
Easiest to access without assistance
Most practiced injection site for insulin users (well-established technique)
Comfortable for both sitting and lying down administration

The thigh is the best second choice. The upper arm is the most difficult to self-administer and is typically a third-line choice or used when the other sites are unavailable.

How to Rotate Injection Sites

Injecting in the same location repeatedly causes lipodystrophy — a buildup of scar tissue that forms lumps under the skin and impairs absorption. Consistent rotation prevents this.

Basic rotation strategy: Divide each site into a grid of quadrants and move through them systematically.

For the abdomen:

Upper right → Upper left → Lower right → Lower left → return to upper right

For thighs:

Right thigh → Left thigh → (alternate)

Weekly rotation example (4-week cycle):

Week 1: Upper right abdomen
Week 2: Upper left abdomen
Week 3: Right outer thigh
Week 4: Left outer thigh
Week 5: Lower right abdomen
Repeat...

Keeping a simple log (a sticky note, phone note, or app) of your last injection site prevents accidental reuse.

Can GLP-1 and Insulin Be Injected at the Same Sites?

Yes, but not at the same spot on the same day. If you use both insulin and a GLP-1 medication:

Both can use the same three injection sites (abdomen, thigh, upper arm)
Do not inject GLP-1 and insulin into adjacent spots during the same session
If insulin is given at the right abdomen in the morning, give your weekly GLP-1 at the left abdomen or thigh
The GLP-1 and insulin rotation schedules should be managed together

Injection Site Reactions: What's Normal vs. Concerning

Normal reactions (temporary, resolve within 24–72 hours):

Redness at the injection site
Mild itching or burning immediately after injection
Small bruise from needle insertion
Slight swelling

Minimize normal reactions:

Let the pen reach room temperature before injecting (30 minutes out of refrigerator)
Use a new needle each injection — dull needles cause more tissue trauma
Insert and withdraw the needle smoothly at 90°
Do not rub the injection site after withdrawal

Concerning reactions (contact your prescriber):

Redness that spreads or grows larger over 24 hours
Significant swelling, warmth, or pus (signs of infection)
Rash or hives beyond the injection site (allergic reaction)
Hard, painful lumps that don't resolve within a week (lipodystrophy from insufficient rotation)

Subcutaneous vs. Intramuscular: Why It Matters

GLP-1 medications must be injected subcutaneously (into fat tissue), not intramuscularly (into muscle). Muscle injections:

Cause significantly more pain
Change the absorption rate (too fast)
Increase local bleeding risk
Are not the intended delivery route for these drugs

To ensure subcutaneous injection: pinch a fold of skin before inserting, use a short (4–6 mm) needle, and insert at 90°. In very lean patients with minimal subcutaneous fat, a 45° angle may be appropriate — discuss with your prescriber.

Needle Recommendations for GLP-1 Pens

GLP-1 pen devices require pen-specific needles (not syringe needles):

Gauge: 31–32 gauge (finer gauge = less discomfort)
Length: 4–6 mm for most patients; up to 8 mm for patients with significant subcutaneous fat
Compatible brands: NovoFine, BD Ultra-Fine, Unifine Pentips, and most standard insulin pen needles

Always use a new needle per injection. Reusing needles causes the tip to become barbed, dramatically increasing injection discomfort and tissue damage.

Bottom Line

Abdomen, outer thigh, and upper arm are the three GLP-1 injection sites — the abdomen is preferred for most patients due to accessibility and consistent absorption. Systematic rotation every week prevents lipodystrophy and maintains predictable drug delivery. Room-temperature medication, fresh needles, and smooth technique are the three most impactful factors for comfortable injections.